- Home
- FLNT vs MURA Comparison
FLNT vs MURA Comparison
Compare FLNT & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- MURA
- Stock Information
- Founded
- FLNT 2001
- MURA 2013
- Country
- FLNT United States
- MURA Ireland
- Employees
- FLNT N/A
- MURA N/A
- Industry
- FLNT Advertising
- MURA
- Sector
- FLNT Consumer Discretionary
- MURA
- Exchange
- FLNT Nasdaq
- MURA Nasdaq
- Market Cap
- FLNT 47.9M
- MURA 45.8M
- IPO Year
- FLNT N/A
- MURA N/A
- Fundamental
- Price
- FLNT $2.25
- MURA $2.30
- Analyst Decision
- FLNT Hold
- MURA Strong Buy
- Analyst Count
- FLNT 1
- MURA 3
- Target Price
- FLNT $3.00
- MURA $12.00
- AVG Volume (30 Days)
- FLNT 22.2K
- MURA 83.7K
- Earning Date
- FLNT 08-18-2025
- MURA 08-12-2025
- Dividend Yield
- FLNT N/A
- MURA N/A
- EPS Growth
- FLNT N/A
- MURA N/A
- EPS
- FLNT N/A
- MURA N/A
- Revenue
- FLNT $243,850,000.00
- MURA N/A
- Revenue This Year
- FLNT N/A
- MURA N/A
- Revenue Next Year
- FLNT $11.62
- MURA N/A
- P/E Ratio
- FLNT N/A
- MURA N/A
- Revenue Growth
- FLNT N/A
- MURA N/A
- 52 Week Low
- FLNT $1.50
- MURA $0.95
- 52 Week High
- FLNT $3.83
- MURA $4.74
- Technical
- Relative Strength Index (RSI)
- FLNT 50.39
- MURA 39.70
- Support Level
- FLNT $2.17
- MURA $2.42
- Resistance Level
- FLNT $2.48
- MURA $2.54
- Average True Range (ATR)
- FLNT 0.28
- MURA 0.07
- MACD
- FLNT -0.01
- MURA -0.01
- Stochastic Oscillator
- FLNT 24.35
- MURA 18.87
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.